Grape King Bio Ltd (1707.TW)

TWD 136.0

(-0.73%)

Market Cap (In TWD)

20.14 Billion

Revenue (In TWD)

10.63 Billion

Net Income (In TWD)

1.45 Billion

Avg. Volume

190.17 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
132.0-163.5
PE
14.01
EPS
9.71
Beta Value
0.436
ISIN
TW0001707008
CUSIP
-
CIK
-
Shares
148137000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Sheng-Lin Tseng
Employee Count
-
Website
https://www.grapeking.com.tw
Ipo Date
2000-01-04
Details
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes. It also provides OEM, ODM, formulation design, research and development, and raw material supply services. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.